NCT06137742 A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06104228 129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH) Status RECRUITING Phase PHASE2
NCT06092424 High Altitude (HA) Residents With Pulmonary Vascular Diseseases (PVD), Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) vs Sea Level (LA) Status ACTIVE_NOT_RECRUITING Phase NA
NCT06072937 IntelliStent for Pulmonary Flow Adjustment in Congenital Heart Disease and Dilated Cardiomyopathy Status NOT_YET_RECRUITING Phase NA
NCT06053580 Repurposing Valsartan May Protect Against Pulmonary Hypertension Status RECRUITING Phase PHASE2
NCT05977933 Assessing the Utility of Submaximal CPET in Treatment Management of PAH Status NOT_YET_RECRUITING Phase N/A
NCT05975905 A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study). Status COMPLETED Phase PHASE2
NCT05968859 A Study of Pulmonary Hypertension Peripheral Limitations Status ACTIVE_NOT_RECRUITING Phase NA
NCT05948644 The Safety, Tolerability, and Pharmacokinetics of TPN171H Tablets in Patients With Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE1
NCT05947032 Supervised Endurance Training Among Pulmonary Arterial Hypertension Patients Status COMPLETED Phase NA
NCT05938946 Safety, Tolerability and Pharmacokinetics of L608 in Healthy Adults Status COMPLETED Phase PHASE1
NCT05934526 Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA) Status COMPLETED Phase PHASE3
NCT05861479 Prognostic Value of Estimated Plasma Volume in Pulmonary Hypertension Status COMPLETED Phase N/A
NCT05825417 Pulmonary Hypertension: Intensification and Personalisation of Combination Rx Status RECRUITING Phase PHASE4
NCT05818137 A Study of Sotatercept in Japanese Pulmonary Arterial Hypertension (PAH) Participants (MK-7962-020) Status COMPLETED Phase PHASE3
NCT05764265 Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Participants Status TERMINATED Phase PHASE2
NCT05745961 Quantifying 18kDa TSPO Expression in the Lung in Pulmonary Artery Hypertension (PAH) Status RECRUITING Phase N/A